Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Well-Respected Clinic in Acworth, Georgia, Dental Care Acworth, Earns the 2023 Top Patient Rated Dentist Award From Find Local Doctors


News Image

“We feel privileged to serve patients and give them access to the most cutting-edge, advanced dental care available in Acworth,” says Dr. Brian Mitchell.

Dental Care Acworth provides the very best in comprehensive dentistry for families, offering an extensive list of advanced dental services for patients of all ages all under one roof. Find Local Doctors has recently recognized Dental Care Acworth as a result of the five-star ratings and reviews the clinic has earned from satisfied patients. Find Local Doctors is a trusted online directory helping consumers easily locate qualified and reputable physicians and dentists in their area. This modern, state-of-the-art clinic provides a friendly, warm environment for patients to receive the ultimate in dental care. Everyone can enjoy the benefit of a gorgeous, healthy smile when they join the dental family at Dental Care Acworth. They offer general and preventive dentistry to protect the health of teeth and gums, as well as many specialized dental services. From clear aligners and cosmetic dental treatments to dental implants and complete tooth restorations, almost everything patients need to improve the health and look of their smiles is available at Dental Care Acworth. Regardless of whether they are protecting, repairing or enhancing smiles, patients can trust the team for superior, individualized attention at every step, and Dental Care Acworth uses advanced dental technology to ensure patients get the highest level of oral care possible. The clinic accepts most dental insurance plans and has easy payment options available to ensure patients can receive the dental treatments and procedures they need when they need them.

“We feel privileged to serve patients and give them access to the most cutting-edge, advanced dental care available in Acworth,” says Dr. Brian Mitchell.

More about Dental Care Acworth:

Dr. Brian Mitchell is an esteemed dentist who is trained in multiple facets of dentistry. This allows Dental Care Acworth to address the specific oral health concerns that patients face at each stage of life, ranging from gum disease and TMJ therapy to dentures and dental implants. Dr. Mitchell grew up in Marietta, Georgia, and has remained in the state for the entirety of his education and career. He completed his undergraduate studies at The University of Georgia and then attended the Medical College of Georgia’s School of Dentistry, earning his dental degree. Dr. Kimi Patel attended the University of Michigan for her BS and earned a doctorate from the University of Michigan College of Dentistry. After completing her dental degree, she moved to Cincinnati, OH, to further her education and complete an AEGD residency (Advanced Education in General Dentistry). Dr. Kimi Patel strives to provide patient-centered, comprehensive, and compassionate care. She values the importance of fostering relationships with her patients so that they feel comfortable and truly heard. For more information about Dental Care Acworth or to schedule an appointment, please visit http://www.dentistinacworth.com or call (678) 888-1554.

Share article on social media or email:

Psychiatric Medical Care Selects Proem Behavioral Health to Help Improve Patient Outcomes


Psychiatric Medical Care will use Proem’s evidence-based behavioral health solution to support its Embrace Health and embrace U initiatives.

Through our partnership with Proem, we gain access to a powerful platform that will help strengthen the services we provide to program participants and better ensure the success of our new initiatives, said Stephanie Weatherly, DNP, PMH RN-BC, FACHE, Chief Clinical Officer for PMC.

Proem Behavioral Health, developer of the evidence-based clinical workflow software engine that helps providers triage patients and produce better mental health outcomes, is pleased to announce that is has executed a license agreement with Psychiatric Medical Care (PMC), a national behavioral healthcare management company with multiple service lines.

Under the terms of the agreement, PMC will have access to Proem’s platform that provides actionable behavioral health data throughout the care process. PMC is leveraging the digital solution to support two of its newer initiatives. The company is incorporating the Proem solution into “Embrace Health,” a virtual, direct-to-consumer clinic currently serving Iowan adults and families, and “embrace U,” an intensive outpatient program for adolescents. The first embrace U program operates out of Brentwood, Tenn.

“At PMC, we are always working to identify the most effective ways to deliver optimal outcomes to our patients,” said Stephanie Weatherly, DNP, PMH RN-BC, FACHE, Chief Clinical Officer for PMC. “Through our partnership with Proem, we gain access to a powerful platform that will help strengthen the services we provide to program participants and better ensure the success of our new initiatives.”

The intelligent workflow engine from Proem captures and shares data at every step of the behavioral healthcare process, providing insight to help providers assess and diagnose mental illness and determine the next steps to take in a patient’s care. This leads to a significant result: better outcomes for patients who suffer from mental illness.

“As a leader in behavioral health, PMC understands the importance of accurate data, timely identification of behavioral health issues, and simplified processes that help providers and patients,” said Proem CEO John Letter. “The selection of Proem by such an impressive organization affirms the ongoing hard work of our team and validates our continuing mission to change the ways we identify, assess, measure, and address mental health problems.”

ABOUT PSYCHIATRIC MEDICAL CARE

Founded in 2003 and based in Nashville, Tenn., Psychiatric Medical Care (PMC) is a leading behavioral healthcare management company focused on addressing the needs of rural and underserved communities. Operating in more than 25 states, the company manages both inpatient psychiatry units and intensive outpatient psychiatry programs within hospitals. PMC also provides telepsychiatry services across a variety of clinical settings. The company’s programs provide evaluation and treatment for patients suffering from behavioral health issues, including depression, anxiety, PTSD, and other mood and cognitive disorders. To learn more, visit http://www.psychmc.com and follow PMC on LinkedIn.

ABOUT PROEM BEHAVIORAL HEALTH

Proem Behavioral Health, formerly nView Health, provides the premier clinical workflow software engine that helps behavioral health providers and research organizations efficiently and accurately screen, test, and measure treatment success for those suffering from mental illness. Proem is the exclusive digital licensee worldwide of gold-standard, evidence-based screening solutions, structured interviews, and post-diagnosis severity measurement scales to monitor patient outcomes. To learn more, visit http://www.proemhealth.com and follow Proem on LinkedIn.

Share article on social media or email:

Healthcare Companies to Face Intensifying Scrutiny of COVID-19 Provider Relief Funds from Government and Whistleblowers


Logo of national law firm Bass, Berry & Sims PLC

Bass, Berry & Sims PLC

“Last year, DOJ made clear its intention to pursue fraud cases related to provider relief funds, [such as] appointing a Director for COVID-19 Fraud Enforcement …. We expect that this is the beginning of a years-long effort.” — Brian D. Roark, Bass, Berry & Sims

In 2022, the federal government set the stage for wider scrutiny of billions of dollars in pandemic relief funds for healthcare provider groups in 2023 and beyond, as described in the Healthcare Fraud & Abuse Review 2022 published today by Bass, Berry & Sims.

In the 11th annual edition of the Review, Bass, Berry & Sims expects more enforcement actions related to funds distributed under the Coronavirus Aid, Relief, and Economic Security (CARES) Act in 2023 and other federal relief programs.

Download the Healthcare Fraud & Abuse Review 2022.

“Last year, DOJ made clear its intention to pursue fraud cases related to provider relief funds, from appointing a Director for COVID-19 Fraud Enforcement to setting up Strike Force Teams dedicated to these cases,” said Brian D. Roark, co-chair of the firm’s Healthcare Fraud & Abuse Task Force. “We expect that this is the beginning of a years-long effort to pursue cases concerning provider relief funds that may involve far more complex circumstances than the blatant fraud that DOJ has prosecuted so far. We also expect whistleblowers to target alleged fraud in use of COVID-19 relief funds in qui tam cases filed under the False Claims Act.”

Bass, Berry & Sims will host a complimentary webinar that will provide an overview and discussion of key focus areas covered in the Review on Wednesday, February 22, from 10:00 a.m.-12:00 p.m. CT. Please click here to register.

Government More Proactive

The Department of Justice’s (DOJ) proactive focus on fraud in COVID-19 relief programs fits a pattern of more government-initiated healthcare fraud enforcement activity overall. In each of the past two years, DOJ has initiated more FCA cases than in any single year since 1995. In the fiscal year that ended Sept. 30, 2022, DOJ recovered $1.7 billion in FCA settlements and judgments related to federal losses involving the healthcare industry. In keeping with percentages from prior years, healthcare-related recoveries represented the overwhelming majority of the $2.2 billion in total FCA settlements in fiscal year 2022, nearing 80%. The total number of FCA settlements, at 351, was the second-highest number in a single year, although recoveries were down from $5.6 billion in fiscal year 2021.

“The government has continued to invest in its own data analytics and data mining, which has greatly enhanced DOJ’s ability to pursue healthcare fraud cases,” said Matthew M. Curley, co-chair of the Healthcare Fraud & Abuse Task Force and editor of the Review. “

Both COVID-19 relief funds and telehealth also remain the subjects of dedicated enforcement initiatives. With these moves, the federal government continues its proactive approach to healthcare fraud enforcement, in addition to its more traditional approach of investigating the allegations in qui tam cases brought by whistleblowers under the False Claims Act.”

In July 2022, DOJ announced criminal charges against 36 defendants in 13 federal districts alleging $1.2 billion in intended losses associated with fraud schemes involving telemedicine, cardiovascular and cancer genetic testing, and durable medical equipment (DME). At the same time, HHS-OIG issued a Special Fraud Alert concerning telehealth arrangements. The Special Fraud Alert focused on areas where healthcare providers and companies need to be cautious in telehealth arrangements, such as arrangements with limited patient-practitioner relationships and the compensation arrangements of practitioners.

Last year also brought expansion of the federal government’s criminal and civil enforcement related to the opioid epidemic. The success of DOJ’s Appalachian Regional Prescription Opioid (ARPO) Strike Force—which announced charges against 14 persons, including 12 medical professionals in May 2022—led to the creation of the New England Prescription Opioid (NEPO) Strike Force the following month.

“The federal government is scrutinizing every link of the opioid distribution chain, from manufacturers and distributors to pharmacies and individual prescribers,” said Lisa S. Rivera, a member of the Healthcare Fraud & Abuse Task Force and chair of the Firm’s Compliance & Government Investigations Practice Group. “This wide range of possible enforcement targets demonstrates the federal government’s commitment to addressing the opioid epidemic through enforcement efforts, as well as other areas of the broad-ranging Controlled Substances Act. Companies and providers should take great care to abide by all statutory and regulatory requirements related to opioid products and compliance with the CSA.”

Analysis of Major FCA Case Law Trends

The Review provides analysis of major trends in FCA cases law including an in-depth review of developments related to the Stark self-referral law and the Anti-Kickback Statute (AKS).

“Government fraud enforcers and whistleblowers alike continue to scrutinize financial relationships between hospitals, health systems and other provider organizations,” said Anna M. Grizzle, a member of the firm’s Healthcare Fraud & Abuse Task Force who advises clients on enforcement and compliance-related issues. “Healthcare providers must build a robust, up-to-date compliance program and always remain alert to practices that may violate this complex area of healthcare law.”

One of last year’s most significant settlements involved AKS-related allegations against pharmaceutical manufacturer Biogen, which agreed to pay $900 million to resolve a whistleblower lawsuit alleging that the company had offered and paid kickbacks to physicians in the form of speaker honoraria, speaker training fees, consulting fees and meals to induce the physicians to prescribe Biogen’s multiple sclerosis drugs.

This settlement and other AKS-related enforcement actions are covered in detail in the Review. The Review also highlights issues to watch this year and provides a comprehensive review of settlements involving the healthcare industry, grouped by sector:

  • Hospitals and Health Systems
  • Long-Term Care
  • Pharmaceutical and Medical Device Companies
  • Pharmacy Services
  • Lab and Diagnostic Service Providers
  • Behavioral Health
  • Managed Care and Health Plans
  • Specialty Care and Other Provider Entities

Download the Review here; visit the Bass, Berry & Sims Healthcare Fraud & Abuse Resource Center, which features a database of healthcare fraud settlements since 2012; and follow the Inside the False Claims Act blog to stay up to date on FCA matters.

About Bass, Berry & Sims

Bass, Berry & Sims is a national law firm with nearly 350 attorneys dedicated to delivering exceptional service to numerous publicly traded companies and Fortune 500 businesses in significant litigation and investigations, complex business transactions, and international regulatory matters. The firm is ranked as the fifth largest healthcare law firm in the U.S. by Modern Healthcare (2022) and fourth largest by American Health Law Association (2022). For more information, visit http://www.bassberry.com.

Share article on social media or email:

Individuals Allergic to Sesame Could be Desensitized Using Emerging Oral Desensitization Treatment


AAAAI Logo

Our data suggests that there is a significant number of pediatric sesame-allergic patients who could achieve remission of their sesame allergy, or at least have their diet liberalized, in a safe and effective way.

Oral desensitization to sesame can be both safe and effective when using crushed sesame seeds and tahini, new research being presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) suggests.

“The safety data we collected was encouraging,” said Ami Shah, MD, primary author of the study. “During desensitization, 29.1% of the participants experienced allergic reactions of some kind while undergoing daily dosing, but only one allergic reaction required the use of epinephrine, showing that this oral desensitization treatment can be safely done under the right conditions with a qualified healthcare professional.”

While oral desensitization is an emerging treatment for food allergies, little research has been completed in the United States on using this method for sesame. Researchers completed a retrospective chart review of 86 pediatric patients at a pediatric food allergy referral center who were receiving oral desensitization to sesame. Participants underwent an initial low dose oral food challenge (OFC) to crushed sesame seeds or tahini. Doses were increased until participants reached the maintenance dose, typically of one teaspoon of tahini or 1,000 mg of sesame. Of the participants, 59.3% made it to the maintenance dose, while 30.2% were still working towards maintenance at the time of this study’s completion. Nine patients (10.5%) did not complete desensitization.

In the end, ten of the participants who reached the maintenance dose were able to complete a full dose OFC to one tablespoon of tahini (3,000 mg of sesame protein). All ten participants had a negative OFC then discontinued daily sesame dosing for between four and six weeks before undergoing another OFC. All 10 reported a negative OFC.

“Our data suggests that there is a significant number of pediatric sesame-allergic patients who could achieve remission of their sesame allergy, or at least have their diet liberalized, in a safe and effective way,” said Dr. Shah. “Future studies should be aimed at better understanding sesame allergy thresholds, identifying biomarkers that can help distinguish sesame-allergic patients who will tolerate OIT, and determine the impact that OIT to sesame may have on a patient and their family’s quality of life.”

Visit aaaai.org to learn more about sesame allergy. Research presented at the AAAAI Annual Meeting, February 24-27 in San Antonio, Texas, is published in an online supplement to The Journal of Allergy and Clinical Immunology.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. The AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Share article on social media or email:

PetMeds® Signs Pet Insurance Partnership


News Image

“By giving our customers direct access to pet insurance, we will be able to greatly assist millions of pet parents in getting quality insurance that helps them care for their pets,” said Matt Hulett, CEO and President of PetMed Express.

PetMed Express, Inc. (PetMeds®, NASDAQ: PETS), Your Trusted Pet Health Expert™, today announced it will begin offering access to a high quality health and wellness insurance solution, Pumpkin Insurance Services Inc. (“Pumpkin”), to more than 2 million PetMeds customers.

Providing a quality accident and illness insurance solution is an important social issue because of the low participation rate of insured pets in the United States. The North American Pet Health Insurance Association estimates only 4.4 million pets were insured in 2021, less than 5% of the pet population.

“Today, there is a huge disconnect between the high penetration of pet ownership and the relatively low participation rate in insurance,” said Matt Hulett, CEO and President of PetMed Express. “By giving our customers direct access to pet insurance, we will be able to greatly assist millions of pet parents in getting quality insurance that helps them care for their pets.”

“Pumpkin’s goal has always been to positively impact the lives of millions of pets, pet parents, and veterinarians” said Alexandre Douzet, CEO of Pumpkin Pet Insurance. “Getting the PetMeds’ audience covered with a top-tier accident & illness insurance and optional, non-insurance wellness plan provided by Pumpkin, will drive more pets into veterinary clinics for regular preventive exams, diagnostic screenings, and best medicine.”

This offering is part of PetMeds’ larger “trusted pet health expert” strategy. It marks PetMeds’ third strategic initiative in the last 17 months, following the investment in Vetster in April 2022, which introduced a one-of-a-kind offering for pet parents in the pet telemedicine space. The second is the acquisition of PetCareRX which was recently announced in January 2023.

CapM Advisors acted as financial advisor to PetMeds in developing the strategic initiative.

##

ABOUT PETMEDS

Founded in 1996, PetMed Express is Your Most Trusted Pet Health Expert®, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at petmeds.com. PetMeds aims to be the most trusted pet health expert by providing incredible care and services that are affordable to the broadest group of pet parents because every pet deserves to live a long, happy, healthy life. For more information, please visit http://www.1800petmeds.com.

PETMEDS MEDIA CONTACT

Mary Eva Tredway

Butin PR

maryeva@butinpr.com

Share article on social media or email:

Revuud and Texas Hospital Association Partner to Revolutionize Healthcare IT Hiring


“We are thrilled to be working with THA and healthcare organizations in Texas to provide them with access to the best IT talent in the market,” said Eric Utzinger, CEO and Co-Founder of Revuud.

Revuud, a leading healthcare IT staffing marketplace, has joined forces with the Texas Hospital Association (THA) to change the game for healthcare organizations seeking top engineering talent. The dynamic duo is empowering a connected community of Healthcare Systems and highly qualified healthcare IT professionals to collaborate, without the need for a recruiter.

With the growing demand for skilled engineers in the healthcare industry, this partnership provides a much-needed solution that streamlines the hiring process, saves time, and offers access to a network of top IT talent. The platform provides healthcare organizations with the ability to quickly search and connect with IT candidates, review their portfolios, and evaluate their credentials and references, all in one place.

“We are thrilled to be working with THA and healthcare organizations in Texas to provide them with access to the best IT talent in the market,” said Eric Utzinger, CEO and Co-Founder of Revuud. “With this partnership, we are committed to making the hiring process faster, more efficient, and more effective for both healthcare systems and IT professionals.

“This strategic alliance brings numerous benefits to Texas healthcare organizations, including a wider pool of qualified IT candidates, reduced time to hire, and significantly lower hiring costs. IT professionals will also reap the rewards, with higher average pay, increased exposure to a wide range of healthcare organizations searching for top talent and a platform to showcase their skills and experience.

“Healthcare organizations in Texas are facing significant challenges when it comes to hiring top IT talent,” said Alex Huff, the VP of Health Technology Innovation for THA . “Our partnership with Revuud will help these organizations overcome these challenges and build a stronger, more effective IT team.

“With the new partnership in place, healthcare organizations in Texas can feel confident that they are working with a trusted partner to find the best IT talent for their needs, without the hassle and expense of traditional recruiting methods.

About Revuud

Revuud is a leading healthcare IT staffing marketplace that helps healthcare organizations connect with top engineering talent. Our mission is to revolutionize the way healthcare organizations hire IT talent by providing a faster, more efficient, and cost-effective solution. With our platform, healthcare organizations can easily search and connect with IT candidates, review their portfolios, and evaluate their credentials and references, all in one place. For more information, please visit http://www.revuud.com.

About THA

Founded in 1930, the Texas Hospital Association is the leadership organization and principal advocate for the state’s hospitals and health care systems. Based in Austin, THA enhances its members’ abilities to improve accessibility, quality and cost-effectiveness of health care for all Texans. One of the largest hospital associations in the country, THA represents 452 of the state’s non-federal general and specialty hospitals and health care systems, which employ some 400,000 health care professionals statewide. Learn more about THA at http://www.tha.org or follow THA on Twitter at http://twitter.com/texashospitals.

Share article on social media or email:



AZZLY® Partners with Zoom® to Provide Secure Telehealth Sessions Seamlessly From AZZLY Rize™ All-in-One Mental Health Platform


News Image

We are excited to provide Zoom as an integrated solution within our platform. The enhanced features and functionality is a plus for all telehealth providers and the patients that they serve. […] Keeping it easy to schedule, invite, remind, launch, join and bill made this an easy decision.

AZZLY, Inc., a leading behavioral and addiction treatment digital health solution, announced today that it has formed an Independent Software Vendor (ISV) Partnership with the leader in digital video conferencing solutions, Zoom.

As an all-in-one platform, AZZLY helps transform treatment centers to run more efficiently. Having Zoom virtual meetings available as a single sign on solution for all telehealth providers allows for appointment reminders, to record attendance, duration of sessions and no-shows, sharing of presentation material, educational links, group sessions, closed caption and more. Real time documentation means notes get completed timely for prompt reimbursement of services.

AZZLY Rize empowers your staff through its simplicity and automation. Key clinical and business features include e-check-in, scheduling, appointment reminder, EHR, telehealth, treatment plans, progress notes, outcome measurement tools, medication management, bed board, withdrawal management, e-prescribing, EPCS, PDMP, patient communication tools, reporting and electronic billing and claims submission.

As a true all-in-one addiction treatment and mental healthcare-specific electronic health record (EHR) and revenue cycle management (RCM) platform, improved compliance and accurate coding are achieved real-time. AZZLY proudly serves providers in over 31 states and is hosted in Microsoft Azure’s private cloud network. AZZLY serves the clinical and business needs of small, medium, and large organizations across all Levels of Care (LOC) and Programs offered.

“We are excited to provide Zoom as an integrated solution within our platform. The enhanced features and functionality is a plus for all telehealth providers and the patients that they serve.” said Coletta Dorado, Founder and CEO of AZZLY. “Almost everyone is familiar with Zoom, patients and providers, so keeping it easy to schedule, invite, remind, launch, join and bill made this an easy decision.”

March 9, 2023, AZZLY will host a webinar titled “Telehealth Models of Success”. The webinar is a panel-style discussion with experts in the field of mental healthcare and addiction treatment. Join us to learn how each of the panelists successfully utilized telehealth to expand their treatment programs. Register here: eventbrite.com/e/telehealth-models-of-success-tickets-537817876747.

Additionally, on March 16, 2023, another webinar will follow titled ”How to Use One Platform: AZZLY Rize™ + Zoom For Your Telehealth Model”. Attend to hear perspectives from both AZZLY and Zoom experts on the partnership and best practices for using telehealth within AZZLY’s all-in-one platform. Attendees will see a demonstration of the Zoom virtual capabilities within AZZLY Rize.. Register for either webinar at eventbrite.com/o/azzly-inc-60174844843 and follow AZZLY for updates on future webinars.

About AZZLY, Inc.:

Coletta Dorado founded AZZLY®, Inc. in 2009. Since 2014, AZZLY leadership has focused all resources on its behavioral healthcare platform, AZZLY Rize™, to meet the specific clinical and business needs of addiction treatment and mental healthcare organizations. AZZLY was recognized as a key player in the Global Patient Care Management Software industry (2020), on the Capterra® Shortlist™ for Mental Health Software (2021), a Software Advice ® Frontrunner™ for Mental Health Software (2021), and an honorable mention for the Healthiverse Heroes Awards™ by DrFirst® (2022). Email hello@azzly.com or visit azzly.com for more information.

Share article on social media or email:

Successful Approaches from Rare Disease and Cellular and Gene Therapy Product Approvals, Upcoming Webinar Hosted by Xtalks


A hub and spoke model for treating and referral sites allows efficient recruitment planning and wide patient study access, however, challenges the study execution with long-distance or cross-border patient management.

Clinical development is becoming increasingly complex with continuing innovations in cell and gene therapies, especially when factoring in the hurdles of rare disease research. To achieve cell and gene therapy approvals in rare diseases, it is essential to overcome challenges specific to these trials.

Common clinical challenges to consider when planning trials include the complexities related to gene therapy and underlying conditions, as well as needing to monitor patient visits closely and efficiently after administration to ensure study endpoint protection. Operational considerations are often associated with patient recruitment, retention, compliance and challenges behind long-term patient follow-up. A hub and spoke model for treating and referral sites allows efficient recruitment planning and wide patient study access, however, challenges the study execution with long-distance or cross-border patient management.

Additionally, the regulatory landscape continues to evolve to meet challenges with the ongoing development of innovative types of gene therapy, including gene editing, as well as the need for regulatory guidance and flexibility to ensure that a rare disease therapy’s development strategy will meet regulator expectations. Rare disease studies must consider the constraint of very low patient numbers while also needing to achieve appropriate statistical significance to demonstrate efficacy and meet regulatory expectations; having early and regular interactions with regulators to ensure agreement of proposed study designs is essential. Receiving Orphan Drug Designation for a product in development is an important milestone and provides numerous incentives, including regulatory assistance, which helps to facilitate interactions with the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) and other authorities from around the world.

Register now for the webinar on Rare Disease Day 2023 to join the discussion with Medpace medical, regulatory and operational experts on successful approaches for achieving cell and gene therapy approvals in rare diseases.

Join experts from Medpace, Terence Eagleton, MB BS, BSc, Senior Medical Director; Marco Tangelder, MD, PhD, Senior Medical Director; Laura Omoboni, MS, Executive Director, Clinical Trial Management; and Trevor Walker, DPhil, Senior Director, Regulatory Affairs, for the live webinar on Tuesday, February 28, 2023, at 1pm EST (10am PST).

For more information, or to register for this event, visit Successful Approaches from Rare Disease and Cellular and Gene Therapy Product Approvals.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Claire’s Place Foundation Executive Director to Speak at BreatheCon 2023


“I am honored to be a presenter at BreatheCon 2023,” said Claire’s Place Foundation Executive Director Melissa Yeager.

Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is pleased to announce that their Work Proudly Program will be featured at the Cystic Fibrosis Foundation’s BreatheCon 2023, February 23-25, 2023. Claire’s Place Foundation Executive Director Melissa Yeager will present the purpose and success of the Work Proudly Program at the virtual event.

The seventh annual BreatheCon, hosted by the Cystic Fibrosis Foundation, is a unique online event for adults with CF to safely gather virtually. The event is an inclusive space to participate in timely discussions, affinity groups, creative activities and more.

A recipient of the CF Foundation’s Impact Grant and Community Support Grant, the Claire’s Place Work Proudly Program was chosen to be featured in BreatheCon’s Community Program Showcase. The purpose of the Showcase is to highlight projects led by the CF community that support and empower people living with CF. The Claire’s Place presentation will be on February 23rd at 5:30 pm PST.

The Claire’s Place Work Proudly Program provides job training and equipment needed for work-from-home employment to adults with CF and caregivers. The program allows participants to gain the skills and access technology to be competitive in the job market and acquire flexible, work-from-home or hospital employment. Participants are recruited through a social worker referral.

“I am honored to be a presenter at BreatheCon 2023,” said Claire’s Place Foundation Executive Director Melissa Yeager. “We have been overwhelmed by the positive impact and demand for our Work Proudly Program since we launched it in 2020. I look forward to sharing success stories of our participants as well as answering questions and connecting with the BreatheCon attendees.”

If you are an adult with CF and would like to attend BreatheCon 2023 visit here to register.

About Claire’s Place Foundation, Inc.

Claire’s Place Foundation, Inc. is a 501(c)(3) non-profit organization providing support to children and families affected by cystic fibrosis (CF). Claire’s Place Foundation is named in honor of Claire Wineland who lived with CF her entire life and died at the age of 21. Claire was an activist, author, TEDx Speaker, social media star and received numerous awards. Claire’s foundation was a way for her to assure that others living with CF enjoyed the same hope, strength and joy that she enjoyed. Recipient of Los Angeles Business Journal’s “Small Nonprofit of the Year” and “Fundraiser of the Year” for its annual Glow Ride, the foundation provides grants to families affected by CF, offering both emotional and financial support. Today, Claire’s Place Foundation continues to carry on Claire’s legacy. For more information and make a donation, please visit http://www.clairesplacefoundation.org.

Share article on social media or email:

Ideal Option Partners with Snohomish County and Others to Host Take Back and Recovery Event


Ideal Option, a national leader in outpatient medication-assisted treatment for opioids, methamphetamine, alcohol and polysubstance, is partnering with Holman Recovery Center, Snohomish County Health Department, Marysville Police Department, EvergreenHealth Monroe, Providence, Catholic Community Services, A1 Lifeline, Washington 2-1-1, and The Hand Up Project to help people in Marysville get started in recovery.

According to the Medical Examiner’s Office Drug Overdose Dashboard, in Snohomish County alone, there were 162 overdose deaths involving opioids in 2022, with 141 of those involving fentanyl.

Ideal Option data support the effectiveness of medication-assisted treatment for opioid use disorder. Among patients who remained in treatment with Ideal Option during 2021, urine drug testing shows 98% less fentanyl use and 93% less total opioid use.

Recovery Starts Today! will take place on Friday, February 24, 10 a.m. – 2 p.m. at the Ideal Option clinic in Marysville located at 1617 Grove St. Attendees can surrender illicit substances and paraphernalia for safe disposal, learn about community resources, complete intake and, if desired, see a provider immediately to start medication-assisted treatment. For nearly all patients, costs are covered by Medicaid or private insurance.

This event is designed to empower those in the community who are struggling with the disease of addiction to come forward without fear of legal repercussions and begin their recovery with medication-assisted treatment.

For questions about this event, email Senior Marketing Manager Olivia Roe at oliviaroe@idealoption.net.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 84 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email: